menu
Investigator at the Translational Research Institute
Translational Research
Dr. Corbin is an Investigator at the Translational Research Institute of Metabolism and Diabetes. Her program of research focuses on enterohepatic metabolism and the mechanisms that drive individual susceptibility to metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), diabetes and obesity.
Dr. Corbin came to the TRI-MD after a 3-year term as a Research Assistant Professor at UNC Chapel Hill, Gillings School of Global Public Health, Department of Nutrition. Dr. Corbin earned her doctorate degree in molecular medicine at the University of South Florida College of Medicine in 2008. She became a registered dietitian in 1998 after completing her dietetic internship at the James A. Haley Veteran’s Hospital in Tampa, FL. She earned her Bachelor’s Degree in Nutrition and Food Science in 1997 at Florida State University.
Dr. Corbin’s research portfolio includes both investigator-initiated and industry clinical-translational studies focused on novel pathogenic mechanisms and therapeutics. Her work is highly innovative and transdisciplinary and has the potential to lead to important advances in prevention and treatment strategies for common metabolic diseases.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
2020
ENDOCRINE REVIEWS
2018
CURRENT DIABETES REPORTS
2017
REPRODUCTIVE TOXICOLOGY
2016
University of South Florida College of Medicine
James A. Haley Veteran's Hospital, Tampa, FL
This study is currently enrolling.
The purpose of this study is to screen individuals for non-alcoholic fatty liver disease (NAFLD). This disease occurs often in people that are obese or have diabetes. In some people, it can get worse and cause scarring an ...
This study is currently enrolling.
Non-alcoholic fatty liver disease (NAFLD), is very common and many people do not know that they have it. Risk for developing NAFLD can be increased by genetics, lifestyle and other factors. NAFLD can increase your risk o ...
This study is currently enrolling.
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH or NAFL in clinical practice. TARGET-NASH will create a carefully maintained, actively monitored research registry of patients wi ...